“A Prescription for Competition”: DOJ Antitrust Division Affirms Its Enforcement Focus on the Healthcare Industry

U.S. Antitrust, Competition & Trade Regulation and Health Care Alert

The healthcare industry remains a “high enforcement priority” for the U.S. Department of Justice (DOJ) and the Federal Trade Commission, according to statements last week by a senior official in the DOJ’s Antitrust Division.

In prepared remarks at the American Bar Association’s Antitrust in Healthcare Conference, Deputy Assistant Attorney General Barry Nigro outlined those “healthcare-related issues on which the Antitrust Division is focused,” highlighting criminal enforcement against price fixing, market allocation, and employee no-poach agreements, as well as describing the government’s willingness to bring civil actions against violators of U.S. antitrust laws to recover damages on behalf of taxpayers. 

To read the full alert, click here.